Vancomycin-Loaded in situ Gelled Hydrogel as an Antibacterial System for Enhancing Repair of Infected Bone Defects
Shouye Sun,Qian Wang,Bin Zhang,Yutao Cui,Xinghui Si,Gan Wang,Jingwei Wang,Hang Xu,Baoming Yuan,Chuangang Peng
DOI: https://doi.org/10.2147/ijn.s448876
IF: 7.033
2024-10-12
International Journal of Nanomedicine
Abstract:Shouye Sun, 1 Qian Wang, 2 Bin Zhang, 3 Yutao Cui, 1 Xinghui Si, 4 Gan Wang, 1 Jingwei Wang, 1 Hang Xu, 1 Baoming Yuan, 1 Chuangang Peng 1 1 Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China; 2 Department of Otolaryngology, The First Hospital of Jilin University, Changchun, People's Republic of China; 3 Department of Spinal Surgery, The 964th Hospital of PLA Joint Logistic Support Force, Changchun, People's Republic of China; 4 Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, People's Republic of China Correspondence: Baoming Yuan, Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China, Email Purpose: During treatment of infected bone defects, control of infection is necessary for effective bone repair, and hence controlled topical application of antibiotics is required in clinical practice. In this study, a biodegradable drug delivery system with in situ gelation at the site of infection was prepared by integrating vancomycin into a polyethylene glycol/oxidized dextran (PEG/ODEX) hydrogel matrix. Methods: In this work, PEG/ODEX hydrogels were prepared by Schiff base reaction, and vancomycin was loaded into them to construct a drug delivery system with controllable release and degradability. We first examined the microstructure, degradation time and drug release of the hydrogels. Then we verified the biocompatibility and in vitro ability of the release system. Finally, we used a rat infected bone defect model for further experiments. Results: The results showed that this antibacterial system could be completely biodegradable in vivo for 56 days, and its degradation products did not cause specific inflammatory response. The cumulative release of vancomycin from the antibacterial system was 58.3% ± 3.8% at 14 days and 78.4% ± 3.2% at 35 days. The concentration of vancomycin in the surrounding environment was about 1.2 mg/mL, which can effectively remove bacteria. Further studies in vivo showed that the antibacterial system cleared the infection and accelerated repair of infected bone defects in the femur of rats. There was no infection in rats after 8 weeks of treatment. The 3D image analysis of the experimental group showed that the bone volume fraction (BV/TV) was 1.39-fold higher ( p < 0.001), the trabecular number (Tb.N) was 1.31-fold higher ( p < 0.05), and the trabecular separation (Tb.Sp) was 0.58-fold higher than those of the control group ( p < 0.01). Conclusion: In summary, this study clearly demonstrates that a clinical strategy based on biological materials can provide an innovative and effective approach to treatment of infected bone defects. Keywords: infected bone defects, drug delivery system, hydrogel, vancomycin Treatment of infected bone defects caused by open fractures or replacement of prostheses has always been a challenge in orthopaedics. 1 Infection severely impairs osteogenesis, leading to complications, such as osteomyelitis and infected non-union. 2,3 Infection causes a persistent state of excessive local inflammation that impairs osteogenic differentiation and promotes bone resorption. 4 On the other hand, pathogens can directly inhibit bone repair by damaging the extracellular matrix and infecting osteoblast. 5 The standard treatment regimen comprises antimicrobial therapy and bone reconstruction, with antimicrobial intervention being the primary objective. 6 Bone reconstruction can only commence once the infection is effectively controlled. Currently, common treatment methods in the clinic include debridement of the infection site, systemic administration of antibiotics, and implantation of antibiotic-loaded bone cement. 7 Bone cement, as a targeted drug delivery method, usually has advantages over systemic treatments requiring high doses of antibiotics, and can easily lead to drug resistance. 8 Poly (methyl methacrylate) (PMMA) is the main material used in bone cement. 9,10 However, studies have shown that antibiotics embedded in the PMMA matrix may be suddenly or only partially (~10%) released in vivo. 11,12 This cannot ensure a sustained effective concentration of antibiotics at the lesion site and may stimulate antibiotic resistance. Furthermore, sudden release of antibiotics impairs osteoblast function. 13 In addition, non-biodegradable bone cement forms a biofilm in the body, which favors bacterial proliferation and increases the risk of secondary infection. Therefore, add -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology